文献速递临床免疫临床微生物

两种改良两步法算法用于莱姆病血清学诊断的性能比较

Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
PubMed 文献 · J Clin Microbiol · 2024-04-10

本研究比较了Diasorin Liaison化学发光免疫分析(CLIA)改良两步法(MTTT)、Zeus酶联免疫吸附试验(ELISA)MTTT与Zeus ELISA/Viramed免疫印迹标准两步法(STTT)的性能。在537份样本中,91份(16.9%)筛查阳性或可疑,仅57份一线筛查一致阳性,其中19份三种二线方法一致阳性。Diasorin MTTT对IgM的敏感性低于Zeus MTTT和STTT,但IgG敏感性两者均为100%。

要点

  • Diasorin MTTT对IgM的阳性符合率低于Zeus MTTT和免疫印迹。
  • 两种MTTT的IgG阳性符合率均为100%,高于免疫印迹STTT的65.9%。
  • Diasorin MTTT工作流程更快速、自动化,但早期莱姆病IgM检测敏感性不足。

核心结论

  • Diasorin CLIA MTTT对IgM的检测敏感性低于Zeus MTTT和STTT,但IgG敏感性高且工作流程更高效。

研究设计与样本

  • 比较三种血清学算法性能的研究,共纳入537份样本。

主要发现

  • 91份(16.9%)样本一种或以上筛查试验阳性或可疑,其中57份一线筛查一致阳性。
  • 57份一致阳性样本中仅19份三种二线方法均一致阳性。
  • IgM阳性符合率:Diasorin 68.1%,Zeus 89.4%(与免疫印迹比较)。
  • 以2/3共识参考标准,IgM阳性符合率:Diasorin 75.6%,Zeus 97.8%,免疫印迹95.6%;Zeus与Diasorin差异显著(P=0.0094)。
  • IgG阳性符合率:Diasorin和Zeus MTTT均为100%,免疫印迹STTT为65.9%(P=0.0005)。

关键数值与推荐

  • IgM阳性符合率Diasorin 68.1% vs Zeus 89.4%(与免疫印迹比较)。
  • IgM阳性符合率(2/3共识标准):Diasorin 75.6%,Zeus 97.8%,免疫印迹95.6%。
  • IgG阳性符合率:Diasorin和Zeus MTTT均为100%,免疫印迹STTT为65.9%。

临床怎么用

  • Diasorin MTTT自动化程度高、流程快,但IgM敏感性较低,需关注早期莱姆病IgM阴性但IgG阳性的情况。

局限性

  • 评估MTTT和STTT性能的独立数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We compared the performance of a new modified two-tier testing (MTTT) platform, the Diasorin Liaison chemiluminescent immunoassay (CLIA), to the Zeus enzyme-linked immunoassay (ELISA) MTTT and to Zeus ELISA/Viramed immunoblot standard two-tier testing (STTT) algorithm. Of 537 samples included in this study, 91 (16.9%) were positive or equivocal by one or more screening tests. Among these 91 samples, only 57 samples were concordant positive by first-tier screening tests, and only 19 of 57 were concordant by the three second-tier methods. For IgM results, positive percent agreement (PPA) was 68.1% for Diasorin versus 89.4% for Zeus compared to immunoblot. By contrast, the PPA for IgG for both Diasorin and Zeus was 100%. Using a 2-out-of-3 consensus reference standard, the PPAs for IgM were 75.6%, 97.8%, and 95.6% for Diasorin, Zeus, and immunoblot, respectively. The difference between Zeus MTTT and Diasorin MTTT for IgM detection was significant (P = 0.0094). PPA for both Diasorin and Zeus MTTT IgG assays was 100% but only 65.9% for immunoblot STTT (P = 0.0005). In total, second-tier positive IgM and/or IgG results were reported for 57 samples by Diasorin MTTT, 63 by Zeus MTTT, and 54 by Viramed STTT. While Diasorin CLIA MTTT had a much more rapid, automated, and efficient workflow, Diasorin MTTT was less sensitive for the detection of IgM than Zeus MTTT and STTT including in 5 early Lyme cases that were IgM negative but IgG positive. IMPORTANCE: The laboratory diagnosis of Lyme disease relies upon the detection of antibodies to Borrelia species. Standard two tier testing (STTT) methods rely upon immunoblots which have clinical and technical limitations. Modified two-tier testing (MTTT) methods have recently become available and are being widely adopted. There are limited independent data available assessing the performance of MTTT and STTT methods.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Landry ML, Hassan S, Rottmann BG, et al. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease. J Clin Microbiol. 2024. PMID: 38597655. doi:10.1128/jcm.00139-24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。